| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.27 | 8e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |